Clinical Trials Browser

Interventional × Peritoneal Neoplasms × Nivolumab × Clear all

NCT03508570 2025-05-22

Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis

Phase 1 Completed

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, Endometrial Neoplasms

NCT03172416 2024-05-29

PIPAC

Phase 1 Active not recruiting

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms